Education
About Us
Working with TipRanks
Follow Us
Ir-Med Inc (IRME)
:IRME
IRME Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.01 - $0.86
Previous CloseN/A
Volume729.00
Average Volume (3M)103.03K
Market Cap
$3.52M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.14
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding77,238,960
10 Day Avg. Volume80,994
30 Day Avg. Volume103,028
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
IR-Med News
IRME FAQ
What was Ir-Med Inc’s price range in the past 12 months?
Ir-Med Inc lowest stock price was $0.01 and its highest was $0.85 in the past 12 months.
What is Ir-Med Inc’s market cap?
Ir-Med Inc’s market cap is $3.52M.
When is Ir-Med Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Ir-Med Inc’s earnings last quarter?
Currently, no data Available
Is Ir-Med Inc overvalued?
According to Wall Street analysts Ir-Med Inc’s price is currently Overvalued.
Does Ir-Med Inc pay dividends?
Ir-Med Inc does not currently pay dividends.
What is Ir-Med Inc’s EPS estimate?
Ir-Med Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ir-Med Inc have?
Ir-Med Inc has 77,238,960 shares outstanding.
What happened to Ir-Med Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Ir-Med Inc?
Currently, no hedge funds are holding shares in IRME
Company Description
Ir-Med Inc
IR-Med Inc., a development stage medical device company, focuses on the development of infra-red light spectroscopy combined with artificial intelligence technology platform to address diagnostic or medical needs. It is developing PressureSafe, a handheld optical monitoring device to support early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear infection (Otitis Media), a common malady in children. The company is headquartered in Rosh Pina, Israel.
IR-Med (IRME) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.